Histogen received $6M in funding and formed license agreement with Pineworld Capital to develop and commercialize Hair Stimulating Complex (HSC). It looks like it will only be available in China , it didn’t say if they have plans to make this available in other countries.
“Through an exclusive license and supply agreement, Pineworld will focus on clinical development, registration, marketing and sales of the HSC injectable hair growth treatment in China. Under the terms of the license, Histogen will receive milestone payments, a transfer price on the product, and escalating royalties on future sales. Histogen will utilize its patented technology process to manufacture HSC for the China market.”